Pfizer Inc has entered into a series of agreements with Aurobindo Pharma Ltd, a pharmaceutical company based in India, to commercialize medicines that are no longer patent protected, and have lost market exclusivity in the United States and Europe, further progressing its Established Products Business Unit (EPBU) strategy.
The details can be read here.
No comments:
Post a Comment